These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 9156266

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.
    Rio B, Bauduer F, Arrago JP, Zittoun R.
    Bone Marrow Transplant; 1993 Jun; 11(6):471-2. PubMed ID: 8334428
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Parenteral glutamine protects hepatic function during bone marrow transplantation.
    Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA, Burnett AK, Poynton CH.
    Bone Marrow Transplant; 1998 Aug; 22(3):281-4. PubMed ID: 9720743
    [Abstract] [Full Text] [Related]

  • 27. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
    Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, Champlin RE, Henslee-Downey PJ, Herzig RH, Hinterberger W, Klein JP, Prentice HG, Reiffers J, Zwaan FE, Horowitz MM.
    Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
    [Abstract] [Full Text] [Related]

  • 28. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population.
    Sartori MT, Spiezia L, Cesaro S, Messina C, Paris M, Pillon M, Saggiorato G, Pagnan A, Girolami A, Zanesco L, Cella G.
    Thromb Haemost; 2005 Apr; 93(4):682-9. PubMed ID: 15841312
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
    Yoshimi A, Kato K, Maeda N, Matsuyama T, Kojima S.
    Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
    [Abstract] [Full Text] [Related]

  • 30. [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation].
    Salat C, Holler E, Reinhardt B, Kolb HJ, Pihusch R, Neumeister P, Hiller E.
    Med Klin (Munich); 1994 May 15; 89(5):245-7. PubMed ID: 8052177
    [Abstract] [Full Text] [Related]

  • 31. [Tendency to thrombosis following bone marrow transplantation?].
    Tsakiris DA, Huser B, Gratwohl A, Marbet GA.
    Schweiz Med Wochenschr; 1991 Mar 09; 121(10):341-3. PubMed ID: 1902984
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C.
    Haematologica; 2005 Oct 09; 90(10):1396-404. PubMed ID: 16219577
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH, Lee KH, Choi JS, Zang DY, Kim SB, Kim SW, Suh C, Lee JS, Kim WK, Lee YS, Kim SH.
    J Korean Med Sci; 1996 Apr 09; 11(2):118-26. PubMed ID: 8835758
    [Abstract] [Full Text] [Related]

  • 37. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
    Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C.
    Bone Marrow Transplant; 1991 Jun 09; 7(6):467-74. PubMed ID: 1908340
    [Abstract] [Full Text] [Related]

  • 38. Endothelium and bone marrow transplantation.
    Catani L, Gugliotta L, Vianelli N, Nocentini F, Baravelli S, Bandini G, Cirio TM, Tura S.
    Bone Marrow Transplant; 1996 Feb 09; 17(2):277-80. PubMed ID: 8640179
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
    Kami M, Mori S, Tanikawa S, Akiyama H, Onozawa Y, Tanaka T, Okamoto R, Maeda Y, Sasaki T, Kaku H, Matsuura Y, Hiruma K, Sakamaki H.
    Bone Marrow Transplant; 1997 Sep 09; 20(5):397-402. PubMed ID: 9339756
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.